Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times

Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Med (Wars)
Autors principals: Sica, Antonello, Vitiello, Paola, Papa, Alfonso, Calogero, Armando, Sagnelli, Caterina, Casale, Danilo, Mottola, Maria, Svanera, Gino, Dodaro, Concetta Anna, Martinelli, Erika, Troiani, Teresa, Ciardiello, Fortunato, Casale, Beniamino
Format: Artigo
Idioma:Inglês
Publicat: De Gruyter 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884922/
https://ncbi.nlm.nih.gov/pubmed/31844674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2019-0087
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars